Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merit predicts better than expected results:

This article was originally published in Clinica

Executive Summary

Merit Medical Systems, which makes disposable products for use in cardiology and radiology, says its third-quarter results will exceed previous guidance. The South Jordan, Utah company has already exceeded earnings guidance of $0.12 per share in the first two months of the quarter. The third quarter is traditionally its slowest in terms of revenue growth, the company says. "Our business is somewhat resilient to the economic and trying times we are experiencing and continues to be strong," said Fred Lampropoulos, Merit's president. The company also expects a strong fourth quarter, owing to distribution agreements, new product introductions and continued growth in existing product lines.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT073433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel